Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Carmustine (solution for intratumoral injection)

EU orphan designation number: EU/3/02/085
Active ingredient: Carmustine (solution for intratumoral injection)
Indication: Treatment of glioma
Sponsor: ICON Clinical Research (U.K.) Limited
2 Globeside, Globeside Business Park, Marlow, Buckinghamshire SL7 1HZ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2002 Orphan designation EMEA/OD/067/01 (2002)959 of 05/03/2002
03/06/2003 Change of name and/or address of sponsor EMEA/OD/067/01
30/04/2012 Removal of orphan designation from Community Register